To view one of the legal documents below, click on its title.
  of 20
TitlePartiesLaw FirmDateGov Law 
LOAN, SECURITY AND GUARANTY AGREEMENT between FOUNDATION HEALTHCARE, INC., as Borrower  FOUNDATION HEALTHCARE, INC.
 Bank SNB, National Association
 CAPITAL BANK
 FOUNDATION HEALTHCARE, INC
McAfee Taft7/14Unavailable
VIAMET PHARMACEUTICALS, INC. Restricted Stock Agreement  VIAMET PHARMACEUTICALS HOLDINGS LLC
 VIAMET PHARMACEUTICALS, INC
Unavailable7/14Delaware
VIAMET PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2014 Incentive Plan  VIAMET PHARMACEUTICALS HOLDINGS LLC
 VIAMET PHARMACEUTICALS, INC
Unavailable7/14Unavailable
VIAMET PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2014 Incentive Plan  VIAMET PHARMACEUTICALS HOLDINGS LLC
 VIAMET PHARMACEUTICALS, INC
Unavailable7/14Unavailable
SUBLEASE AND SERVICES AGREEMENT between LIGAND PHARMACEUTICALS INCORPORATED as Sublandlord and VIKING THERAPEUTICS, INC. as Subtenant May 21, 2014  VIKING THERAPEUTICS, INC.
 LIGAND PHARMACEUTICALS INCORPORATED
 VIKING THERAPEUTICS, INC
Paul Hastings;McKenna Long7/14Unavailable
NOTTINGHAM HALL LEASE AGREEMENT BY AND BETWEEN NOTTINGHAM HALL IC, LLC AS LANDLORD AND VIAMET PHARMACEUTICALS, INC. AS TENANT May 16, 2012  VIAMET PHARMACEUTICALS HOLDINGS LLC
 American Real Estate Partners
 Brookdale Group, LLC
 Brookdale Six REIT, Inc
 NOTTINGHAM HALL IC, LLC
 VIAMET PHARMACEUTICALS, INC
Unavailable7/14United States
MASTER LICENSE AGREEMENT Dated May 21, 2014 by and between Ligand Pharmaceuticals Incorporated and Metabasis Therapeutics, Inc., on one hand, and Viking Therapeutics, Inc., on the other  VIKING THERAPEUTICS, INC.
 Ligand Pharmaceuticals Incorporated
 Metabasis Therapeutics, Inc
 Viking Therapeutics, Inc
Paul Hastings7/14California
HEDGEPATH PHARMACEUTICALS, INC. Common Stock Purchase Warrant  HEDGEPATH PHARMACEUTICALS, INC.
 HedgePath Pharmaceuticals, Inc
 Hedgepath, LLC
Unavailable6/14Delaware
HEDGEPATH PHARMACEUTICALS, INC. Common Stock Purchase Warrant  HEDGEPATH PHARMACEUTICALS, INC.
 HEDGEPATH PHARMACEUTICALS, INC
 Mayne Pharma Ventures Pty Ltd
Unavailable6/14Delaware
HEDGEPATH PHARMACEUTICALS, INC. EQUITY HOLDERS AGREEMENT Dated As of June 24, 2014 Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 Confidential treatment requested with respect to certain portions hereof denoted with  HEDGEPATH PHARMACEUTICALS, INC.
 Black Robe Capital, LLC
 HEDGEPATH LLC
 HEDGEPATH PHARMACEUTICALS, INC
 MAYNE PHARMA VENTURES PTY LTD
Miller Martin6/14Delaware
ONCOGENEX PHARMACEUTICALS INC. SERIES B W ARRANT T O PURCHASE COMMON STOCK  ONCOGENEX PHARMACEUTICALS, INC.
 ONCOGENEX PHARMACEUTICALS INC
Unavailable6/14New York
ONCOGENEX PHARMACEUTICALS INC. PRE -F UNDED SERIES B W ARRANT T O PURCHASE COMMON STOCK  ONCOGENEX PHARMACEUTICALS, INC.
 ONCOGENEX PHARMACEUTICALS INC
Unavailable6/14New York
ONCOGENEX PHARMACEUTICALS INC. SERIES A W ARRANT T O PURCHASE COMMON STOCK  ONCOGENEX PHARMACEUTICALS, INC.
 ONCOGENEX PHARMACEUTICALS INC
Unavailable6/14New York
PROGENICS PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN  PROGENICS PHARMACEUTICALS INC
 PROGENICS PHARMACEUTICALS, INC
Unavailable6/14Delaware
AGREEMENT AND PLAN OF MERGER AMONG AUXILIUM PHARMACEUTICALS, INC. AND QLT INC. AND QLT HOLDING CORP. AND QLT ACQUISITION CORP. June 25, 2014  AUXILIUM PHARMACEUTICALS INC
 AUXILIUM PHARMACEUTICALS, INC
 QLT Acquisition Corp
 QLT HOLDING CORP
 QLT INC
Nutter McClennen;Skadden Arps6/14Delaware
AGREEMENT AND PLAN OF MERGER AMONG AUXILIUM PHARMACEUTICALS, INC. AND QLT INC. AND QLT HOLDING CORP. AND QLT ACQUISITION CORP. June 25, 2014  QLT INC/BC
 AUXILIUM PHARMACEUTICALS, INC
 QLT Acquisition Corp
 QLT HOLDING CORP
 QLT INC
Nutter McClennen;Skadden Arps6/14Delaware
REVENUE ADJUSTMENT AGREEMENT BY AND BETWEEN INTERMUNE PHARMACEUTICALS, INC. AND CONNETICS CORPORATION JUNE 27, 2000 REVENUE ADJUSTMENT AGREEMENT  VIDARA THERAPEUTICS INTERNATIONAL LTD
 Connetics and Genentech, Inc
 CONNETICS CORPORATION
 INTERMUNE PHARMACEUTICALS, INC
Cooley Godward6/14California
ASSIGNMENT AND OPTION AGREEMENT BY AND BETWEEN INTERMUNE PHARMACEUTICALS, INC. AND CONNETICS CORPORATION JUNE 23, 2000 (SUPERSEDING AND REPLACING THE AMENDED AND RESTATED EXCLUSIVE SUBLICENSE AGREEMENT OF APRIL 27, 1999) ASSIGNMENT AND OPTION AGREEMENT  VIDARA THERAPEUTICS INTERNATIONAL LTD
 CONNETICS CORPORATION
 Genentech, Inc
 INTERMUNE PHARMACEUTICALS, INC
Cooley Godward6/14California
Kindred Healthcare, Inc. 9,000,000 Shares Common Stock ($0.25 par value) plus an option to purchase from the Company up to 1,350,000 additional shares of Common Stock Underwriting Agreement  KINDRED HEALTHCARE, INC
 Morgan Stanley & Co LLC
Gibson Dunn;Cleary Gottlieb;Winston Strawn6/14New York
SABRA HEALTH CARE REIT, INC. 2009 PERFORMANCE INCENTIVE PLAN  SABRA HEALTH CARE REIT, INC.
 SABRA HEALTH CARE REIT, INC
Unavailable6/14Maryland
AMENDED AND RESTATED BYLAWS OF DIPEXIUM PHARMACEUTICALS, INC. (a Delaware Corporation)  DIPEXIUM PHARMACEUTICALS, INC.
 DIPEXIUM PHARMACEUTICALS, INC
Unavailable6/14Delaware
PROGENICS PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN  PROGENICS PHARMACEUTICALS INC
 PROGENICS PHARMACEUTICALS, INC
Unavailable6/14Delaware
MOMENTA PHARMACEUTICALS, INC. 2013 INCENTIVE AWARD PLAN (as amended and restated)  MOMENTA PHARMACEUTICALS INC
 MOMENTA PHARMACEUTICALS, INC
Unavailable6/14Delaware
SALIX PHARMACEUTICALS, LTD. 2014 STOCK INCENTIVE PLAN  SALIX PHARMACEUTICALS LTD
 SALIX PHARMACEUTICALS, LTD
Unavailable6/14Delaware
IDERA PHARMACEUTICALS, INC. 2013 STOCK INCENTIVE PLAN  IDERA PHARMACEUTICALS, INC.
 IDERA PHARMACEUTICALS, INC
Unavailable6/14Delaware
of 20

Browse and Search Tips:

• Click each document title to see a preview and subscription options

• Click the column headers to sort by document title, parties, etc.

• Select the Modify Search button to narrow your search

• Choose a document icon at far right to see a summary of the document details or to see a list of clause headings